{"id":69042,"date":"2015-08-19T17:32:46","date_gmt":"2015-08-19T17:32:46","guid":{"rendered":"http:\/\/www.imperialcrs.com\/blog\/?p=1129"},"modified":"2023-12-14T16:04:02","modified_gmt":"2023-12-14T16:04:02","slug":"the-many-faces-of-clinical-trials","status":"publish","type":"post","link":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/the-many-faces-of-clinical-trials\/","title":{"rendered":"The Many Faces of Clinical Trials"},"content":{"rendered":"

In hopes of pushing the envelope of\u00a0modern medicine, clinical trials are growing increasingly complex. With more interested parties, complexities take on an entirely different meaning.<\/p>\n

Clinical trials typically involve five main stakeholders, and each group has its own views and motivations. Here is what people in those groups are saying about clinical trials from their own perspectives:<\/p>\n

 <\/p>\n

\"B694249D-532D-452D-91A1-F19F06B320BB\"<\/a><\/p>\n

The 5 Faces of Clinical Trials<\/strong><\/p>\n

\n
\n
\n
\n

Patients<\/strong><\/p>\n

Most patients (69 percent) said they have not participated in a clinical trial because they were not made aware of any trials.<\/p>\n

This tells us that our industry needs to do more to educate the public about clinical trials. Too many people are unaware that it\u2019s an option for them. This is likely the reason whyrecruitment tends to be the number one reason studies do not finish on time.<\/p>\n

Site Coordinators<\/strong><\/p>\n

Among site coordinators, 28 percent said that inclusion\/exclusion criteria has the single biggest impact on patient recruitment success.<\/p>\n

How can we put a program into place that can help sites expand their database and their reach?<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n

Investigators<\/strong><\/p>\n

Most investigators (76 percent) said that they are involved in the right amount or too many clinical trials.<\/p>\n

There are competing trials and we\u2019re all vying for the same patient population. But we\u2019re also vying for the site\u2019s resources.<\/p>\n

Sponsors<\/strong><\/p>\n

Most sponsors (70 percent) said the hardest part of patient recruitment is finding the rightinvestigators.<\/p>\n

Big data and electronic health records are helping us get more savvy about identifying the right investigators. But more than 60 percent of investigators do only one or two clinical trials. With a constant churn of new investigators coming on board, additional training may be needed, and that adds to the timeline.<\/p>\n

The FDA<\/strong><\/p>\n

The increase in patients required per drug application has soared 233 percent: from 1,500 in the 1970s to more than 5,000 today. This continues to put patient enrollment as the number one reason trials don\u2019t complete on time.<\/p>\n

 <\/p>\n

Given the challenges across the five groups, \u201cone size does not fit all\u201d is a truism. Eachgroup has a unique role and set of challenges.<\/p>\n<\/div>\n

<\/div>\n
For information on simplifying clinical trials and developing a custom patient recruitment solution, grab your\u00a0free copy of my\u00a0new ebook, Retention Planning for Different Study Types<\/a>.<\/div>\n
<\/div>\n
<\/div>\n","protected":false},"excerpt":{"rendered":"

In hopes of pushing the envelope of\u00a0modern medicine, clinical trials are growing increasingly complex. With more interested parties, complexities take on an entirely different meaning. Clinical trials typically involve five main stakeholders, and each group has its own views and motivations. Here is what people…<\/p>\n","protected":false},"author":26,"featured_media":69684,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[35],"tags":[1830,1836,1833,1838,1831,1834,1837,1832,1839,1835],"class_list":["post-69042","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-patient-recruitment-and-retention","tag-clinical-trial-diversity","tag-clinical-trial-participant-demographics","tag-diversity-and-inclusion-in-studies","tag-diversity-in-medical-research","tag-faces-in-clinical-research","tag-faces-of-participants-in-clinical-trials","tag-inclusive-clinical-trial-practices","tag-inclusivity-in-clinical-trials","tag-participant-representation-in-clinical-studies","tag-representing-diversity-in-research"],"acf":[],"yoast_head":"\nThe Many Faces of Clinical Trials<\/title>\n<meta name=\"description\" content=\"Take a look at the 5 main faces of clinical trials and the motivators behind each one; patients, sponsors, investigators, site coordinators, and the FDA.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/the-many-faces-of-clinical-trials\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Many Faces of Clinical Trials\" \/>\n<meta property=\"og:description\" content=\"Take a look at the 5 main faces of clinical trials and the motivators behind each one; patients, sponsors, investigators, site coordinators, and the FDA.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/the-many-faces-of-clinical-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"Imperial Clinical Research Services Blog\" \/>\n<meta property=\"article:published_time\" content=\"2015-08-19T17:32:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-12-14T16:04:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2015\/08\/The-Many-Faces-of-Clinical-Trials.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"533\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Melynda Geurts\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Melynda Geurts\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/the-many-faces-of-clinical-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/the-many-faces-of-clinical-trials\\\/\"},\"author\":{\"name\":\"Melynda Geurts\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#\\\/schema\\\/person\\\/6ec8a211b006310db2bcb4c3e3642781\"},\"headline\":\"The Many Faces of Clinical Trials\",\"datePublished\":\"2015-08-19T17:32:46+00:00\",\"dateModified\":\"2023-12-14T16:04:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/the-many-faces-of-clinical-trials\\\/\"},\"wordCount\":377,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/the-many-faces-of-clinical-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2015\\\/08\\\/The-Many-Faces-of-Clinical-Trials.jpg\",\"keywords\":[\"Clinical Trial Diversity\",\"Clinical Trial Participant Demographics\",\"Diversity and Inclusion in Studies\",\"Diversity in Medical Research\",\"Faces in Clinical Research\",\"Faces of Participants in Clinical Trials\",\"Inclusive Clinical Trial Practices\",\"Inclusivity in Clinical Trials\",\"Participant Representation in Clinical Studies\",\"Representing Diversity in Research\"],\"articleSection\":[\"Patient Recruitment and Retention\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/the-many-faces-of-clinical-trials\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/the-many-faces-of-clinical-trials\\\/\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/the-many-faces-of-clinical-trials\\\/\",\"name\":\"The Many Faces of Clinical Trials\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/the-many-faces-of-clinical-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/the-many-faces-of-clinical-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2015\\\/08\\\/The-Many-Faces-of-Clinical-Trials.jpg\",\"datePublished\":\"2015-08-19T17:32:46+00:00\",\"dateModified\":\"2023-12-14T16:04:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#\\\/schema\\\/person\\\/6ec8a211b006310db2bcb4c3e3642781\"},\"description\":\"Take a look at the 5 main faces of clinical trials and the motivators behind each one; patients, sponsors, investigators, site coordinators, and the FDA.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/the-many-faces-of-clinical-trials\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/the-many-faces-of-clinical-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/the-many-faces-of-clinical-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2015\\\/08\\\/The-Many-Faces-of-Clinical-Trials.jpg\",\"contentUrl\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2015\\\/08\\\/The-Many-Faces-of-Clinical-Trials.jpg\",\"width\":800,\"height\":533,\"caption\":\"Welt Erde Weltkarte Karte Menschen Leute Gruppe Integration bunt multikulturell Vielfalt Freisteller\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/the-many-faces-of-clinical-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Many Faces of Clinical Trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/\",\"name\":\"Imperial Clinical Research Services Blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#\\\/schema\\\/person\\\/6ec8a211b006310db2bcb4c3e3642781\",\"name\":\"Melynda Geurts\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fce2a48245fa3072c9d1fc33a746863af615e36126d4eb11bf2645e77c28a990?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fce2a48245fa3072c9d1fc33a746863af615e36126d4eb11bf2645e77c28a990?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fce2a48245fa3072c9d1fc33a746863af615e36126d4eb11bf2645e77c28a990?s=96&d=mm&r=g\",\"caption\":\"Melynda Geurts\"},\"description\":\"Former vice president of operations, Imperial Clinical Research Services. Melynda is a veteran health care industry executive with more than 20 years of experience. An in-demand speaker and presenter, she is invited often to present and train worldwide at industry conferences and client events. She has contributed many articles to the patient recruitment industry\u2019s body of knowledge and is extremely passionate when it comes to educating the public about participation in global clinical research opportunities. Melynda is a past-inductee into the PharmaVoice 100 Most Inspiring People in the Life-Sciences.\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/author\\\/mgeurts\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Many Faces of Clinical Trials","description":"Take a look at the 5 main faces of clinical trials and the motivators behind each one; patients, sponsors, investigators, site coordinators, and the FDA.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/the-many-faces-of-clinical-trials\/","og_locale":"en_US","og_type":"article","og_title":"The Many Faces of Clinical Trials","og_description":"Take a look at the 5 main faces of clinical trials and the motivators behind each one; patients, sponsors, investigators, site coordinators, and the FDA.","og_url":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/the-many-faces-of-clinical-trials\/","og_site_name":"Imperial Clinical Research Services Blog","article_published_time":"2015-08-19T17:32:46+00:00","article_modified_time":"2023-12-14T16:04:02+00:00","og_image":[{"width":800,"height":533,"url":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2015\/08\/The-Many-Faces-of-Clinical-Trials.jpg","type":"image\/jpeg"}],"author":"Melynda Geurts","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Melynda Geurts","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/the-many-faces-of-clinical-trials\/#article","isPartOf":{"@id":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/the-many-faces-of-clinical-trials\/"},"author":{"name":"Melynda Geurts","@id":"https:\/\/www.imperialcrs.com\/blog\/#\/schema\/person\/6ec8a211b006310db2bcb4c3e3642781"},"headline":"The Many Faces of Clinical Trials","datePublished":"2015-08-19T17:32:46+00:00","dateModified":"2023-12-14T16:04:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/the-many-faces-of-clinical-trials\/"},"wordCount":377,"commentCount":0,"image":{"@id":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/the-many-faces-of-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2015\/08\/The-Many-Faces-of-Clinical-Trials.jpg","keywords":["Clinical Trial Diversity","Clinical Trial Participant Demographics","Diversity and Inclusion in Studies","Diversity in Medical Research","Faces in Clinical Research","Faces of Participants in Clinical Trials","Inclusive Clinical Trial Practices","Inclusivity in Clinical Trials","Participant Representation in Clinical Studies","Representing Diversity in Research"],"articleSection":["Patient Recruitment and Retention"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/the-many-faces-of-clinical-trials\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/the-many-faces-of-clinical-trials\/","url":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/the-many-faces-of-clinical-trials\/","name":"The Many Faces of Clinical Trials","isPartOf":{"@id":"https:\/\/www.imperialcrs.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/the-many-faces-of-clinical-trials\/#primaryimage"},"image":{"@id":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/the-many-faces-of-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2015\/08\/The-Many-Faces-of-Clinical-Trials.jpg","datePublished":"2015-08-19T17:32:46+00:00","dateModified":"2023-12-14T16:04:02+00:00","author":{"@id":"https:\/\/www.imperialcrs.com\/blog\/#\/schema\/person\/6ec8a211b006310db2bcb4c3e3642781"},"description":"Take a look at the 5 main faces of clinical trials and the motivators behind each one; patients, sponsors, investigators, site coordinators, and the FDA.","breadcrumb":{"@id":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/the-many-faces-of-clinical-trials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/the-many-faces-of-clinical-trials\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/the-many-faces-of-clinical-trials\/#primaryimage","url":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2015\/08\/The-Many-Faces-of-Clinical-Trials.jpg","contentUrl":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2015\/08\/The-Many-Faces-of-Clinical-Trials.jpg","width":800,"height":533,"caption":"Welt Erde Weltkarte Karte Menschen Leute Gruppe Integration bunt multikulturell Vielfalt Freisteller"},{"@type":"BreadcrumbList","@id":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/the-many-faces-of-clinical-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.imperialcrs.com\/blog\/"},{"@type":"ListItem","position":2,"name":"The Many Faces of Clinical Trials"}]},{"@type":"WebSite","@id":"https:\/\/www.imperialcrs.com\/blog\/#website","url":"https:\/\/www.imperialcrs.com\/blog\/","name":"Imperial Clinical Research Services Blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.imperialcrs.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.imperialcrs.com\/blog\/#\/schema\/person\/6ec8a211b006310db2bcb4c3e3642781","name":"Melynda Geurts","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/fce2a48245fa3072c9d1fc33a746863af615e36126d4eb11bf2645e77c28a990?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fce2a48245fa3072c9d1fc33a746863af615e36126d4eb11bf2645e77c28a990?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fce2a48245fa3072c9d1fc33a746863af615e36126d4eb11bf2645e77c28a990?s=96&d=mm&r=g","caption":"Melynda Geurts"},"description":"Former vice president of operations, Imperial Clinical Research Services. Melynda is a veteran health care industry executive with more than 20 years of experience. An in-demand speaker and presenter, she is invited often to present and train worldwide at industry conferences and client events. She has contributed many articles to the patient recruitment industry\u2019s body of knowledge and is extremely passionate when it comes to educating the public about participation in global clinical research opportunities. Melynda is a past-inductee into the PharmaVoice 100 Most Inspiring People in the Life-Sciences.","url":"https:\/\/www.imperialcrs.com\/blog\/author\/mgeurts\/"}]}},"_links":{"self":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts\/69042","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/comments?post=69042"}],"version-history":[{"count":1,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts\/69042\/revisions"}],"predecessor-version":[{"id":69324,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts\/69042\/revisions\/69324"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/media\/69684"}],"wp:attachment":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/media?parent=69042"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/categories?post=69042"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/tags?post=69042"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}